EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting androgen receptor signaling to enhance cancer immunotherapy

David A Bader, Binita Chakraborty, Donald P McDonnell, Matthew D Hirschey

Trends in Pharmacological Sciences · 2026-11 · 47 (11) · 1252-1267

DOI: 10.1016/j.tips.2025.11.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-11. Verfasst von David A Bader und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Division of Medical Oncology, Duke University School of Medicine, Durham…. Hauptthemen laut MEDLINE: Receptors, Androgen, Immunotherapy, Neoplasms, Androgen Receptor Antagonists. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Conquer Cancer Foundation, American Society of Clinical Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenImmunotherapyNeoplasmsAndrogen Receptor AntagonistsHumansSignal TransductionAnimalsMaleProstatic NeoplasmsImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

androgen deprivation therapyandrogen receptorcancer immunotherapyimmune checkpoint blockadesex-based differences in cancertumor immune microenvironment

Substanzen

Receptors, AndrogenAndrogen Receptor AntagonistsAR protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Division of Medical Oncology, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Duke Molecular Phys…
  • Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
  • Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
  • Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA; Duke Molecular Physiology Institute, Durham, NC, USA; Pharmacology and Cancer Biology, Duke University…

Förderung

  • NCI NIH HHS
  • Conquer Cancer Foundation
  • American Society of Clinical Oncology
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Bader, D. A., Chakraborty, B., McDonnell, D. P., & Hirschey, M. D. (2026). Targeting androgen receptor signaling to enhance cancer immunotherapy. Trends in Pharmacological Sciences, 47(11), 1252-1267. https://doi.org/10.1016/j.tips.2025.11.003

Vancouver

Bader DA, Chakraborty B, McDonnell DP, Hirschey MD. Targeting androgen receptor signaling to enhance cancer immunotherapy. Trends in Pharmacological Sciences. 2026;47(11):1252-1267. doi:10.1016/j.tips.2025.11.003

BibTeX
@article{Bader2026,
  author = {Bader, David A and Chakraborty, Binita and McDonnell, Donald P and Hirschey, Matthew D},
  title = {Targeting androgen receptor signaling to enhance cancer immunotherapy},
  journal = {Trends in Pharmacological Sciences},
  year = {2026},
  volume = {47},
  number = {11},
  pages = {1252--1267},
  doi = {10.1016/j.tips.2025.11.003}
}
Kostenlos starten →